176 related articles for article (PubMed ID: 16569757)
21. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats.
Peckham EM; Traynor JR
J Pharmacol Exp Ther; 2006 Mar; 316(3):1195-201. PubMed ID: 16291875
[TBL] [Abstract][Full Text] [Related]
23. The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat.
Tejwani GA; Rattan AK
Anesth Analg; 2002 Jun; 94(6):1542-6, table of contents. PubMed ID: 12032023
[TBL] [Abstract][Full Text] [Related]
24. Effects of thienorphine on release of dopamine and noradrenalin: an in vivo microdialysis study in rats.
Yong Z; Yan L; Zhou P; Yu G; Dong H; Gong Z
Neurosci Lett; 2012 Apr; 513(2):132-6. PubMed ID: 22361364
[TBL] [Abstract][Full Text] [Related]
25. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
26. The first universal opioid ligand, (2S)-2-[(5R,6R,7R,14S)-N-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylpentan-2-ol (BU08028): characterization of the in vitro profile and in vivo behavioral effects in mouse models of acute pain and cocaine-induced reward.
Khroyan TV; Polgar WE; Cami-Kobeci G; Husbands SM; Zaveri NT; Toll L
J Pharmacol Exp Ther; 2011 Mar; 336(3):952-61. PubMed ID: 21177476
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
[TBL] [Abstract][Full Text] [Related]
28. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
29. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence.
Codd EE; Carson JR; Colburn RW; Stone DJ; Van Besien CR; Zhang SP; Wade PR; Gallantine EL; Meert TF; Molino L; Pullan S; Razler CM; Dax SL; Flores CM
J Pharmacol Exp Ther; 2009 Apr; 329(1):241-51. PubMed ID: 19151246
[TBL] [Abstract][Full Text] [Related]
30. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
31. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
32. The effect of chronic thienorphine administration on long-term potentiation and synaptic structure in rat hippocampus.
Yong Z; Yan L; Dong Z; Wang X; Su R; Gong Z
Synapse; 2013 Nov; 67(11):779-85. PubMed ID: 23723052
[TBL] [Abstract][Full Text] [Related]
33. A novel long-acting analgesic: buprenorphine palmitate in rats.
Que J; Lin LC; Liu SY; Chu CC; Liu KS; Ho ST; Wang JJ
Acta Anaesthesiol Taiwan; 2005 Mar; 43(1):11-6. PubMed ID: 15868999
[TBL] [Abstract][Full Text] [Related]
34. The depot of buprenorphine decanoate produced a dose-related long-lasting antinociceptive effect in guinea pigs.
Wu SZ; Liu KS; Chu KS; Cheng KI; Kuei CH; Wang JJ; Tzeng JI
Acta Anaesthesiol Taiwan; 2006 Sep; 44(3):161-8. PubMed ID: 17037004
[TBL] [Abstract][Full Text] [Related]
35. [(3)H]Alvimopan binding to the micro opioid receptor: comparative binding kinetics of opioid antagonists.
Cassel JA; Daubert JD; DeHaven RN
Eur J Pharmacol; 2005 Sep; 520(1-3):29-36. PubMed ID: 16165125
[TBL] [Abstract][Full Text] [Related]
36. C-Homomorphinan Derivatives as Lead Compounds to Obtain Safer and More Clinically Useful Analgesics.
Ishikawa K; Karaki F; Tayama K; Higashi E; Hirayama S; Itoh K; Fujii H
Chem Pharm Bull (Tokyo); 2017; 65(10):920-929. PubMed ID: 28966276
[TBL] [Abstract][Full Text] [Related]
37. Effects of thienorphine on synaptic structure and synaptophysin expression in the rat nucleus accumbens.
Yong Z; Yan L; Gao X; Gong Z; Su R
Neuroscience; 2014 Aug; 274():53-8. PubMed ID: 24861887
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC
J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964
[TBL] [Abstract][Full Text] [Related]
39. Deep understanding of the interaction between thienorphine and UDP-glucuronosyltransferase (UGT) isoforms.
Dong RH; Fang ZZ; Zhu LL; Ge GB; Li XB; Hu CM; Cao YF; Xia YL; Yang L; Liu ZY
Xenobiotica; 2013 Feb; 43(2):133-9. PubMed ID: 22813462
[TBL] [Abstract][Full Text] [Related]
40. Combination of cell culture assays and knockout mouse analyses for the study of opioid partial agonism.
Ide S; Minami M; Sora I; Ikeda K
Methods Mol Biol; 2010; 617():363-74. PubMed ID: 20336435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
